Daisuke Ikeda
Hokkaido University
13 Papers
68 Citations
Daisuke Ikeda is an academic researcher from Hokkaido University. The author has contributed to research in topics: Pulmonary hypertension & Medicine. The author has an hindex of 11, co-authored 13 publications.
Chat about Author
Papers
Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis
Shinji Ishimaru,Ichizo Tsujino,Toshiki Takei,Eriko Tsukamoto,Shinji Sakaue,Mitsunori Kamigaki,Naofumi Ito,Hiroshi Ohira,Daisuke Ikeda,Nagara Tamaki,Masaharu Nishimura +10 more
TL;DR: F-FDG PET has the potential to detect cardiac sarcoidosis that cannot be diagnosed by (67)Ga or (99m)Tc-MIBI scintigraphy.
Associations among the plasma amino acid profile, obesity, and glucose metabolism in Japanese adults with normal glucose tolerance
Chisa Takashina,Ichizo Tsujino,Taku Watanabe,Shinji Sakaue,Daisuke Ikeda,Asuka Yamada,Takahiro Sato,Hiroshi Ohira,Yoshinori Otsuka,Noriko Oyama-Manabe,Yoichi M. Ito,Masaharu Nishimura +11 more
TL;DR: The present study identified specific associations between 10 AAs and the type/degree of obesity, and indices of glucose/insulin regulation, in Japanese adults with preserved glucose metabolism.
Addition of oral sildenafil to beraprost is a safe and effective therapeutic option for patients with pulmonary hypertension.
Daisuke Ikeda,Ichizo Tsujino,Hiroshi Ohira,Naofumi Itoh,Mitsunori Kamigaki,Shinji Ishimaru,Shinji Sakaue,Masaharu Nishimura +7 more
TL;DR: Addition of oral sildenafil to beraprost appears to represent a safe and effective therapeutic option, at least in the acute phase, for patients with pulmonary hypertension.
44
Paradoxical Interventricular Septal Motion as a Major Determinant of Late Gadolinium Enhancement in Ventricular Insertion Points in Pulmonary Hypertension
Takahiro Sato,Ichizo Tsujino,Hiroshi Ohira,Noriko Oyama-Manabe,Yoichi M. Ito,Teruo Noguchi,Asuka Yamada,Daisuke Ikeda,Taku Watanabe,Masaharu Nishimura +9 more
TL;DR: LGE at VIPs seen in patients with PH appears to reflect altered IVS motion rather than elevated RV pressure or remodeling, including the paradoxicalIVS motion index.
Pilot study of short-term effects of a novel long-acting oral beraprost in patients with pulmonary arterial hypertension.
Daisuke Ikeda,Ichizo Tsujino,Shinji Sakaue,Hiroshi Ohira,Naofumi Itoh,Mitsunori Kamigaki,Shinji Ishimaru,Tatsuya Atsumi,Masaharu Nishimura +8 more
TL;DR: A novel long-acting oral beraprost (TRK-100STP: 0-360 mug/day for 12 weeks) was administered to 4 patients with mild to moderate PAH and the patients tolerated the drug well with mild adverse manifestations and negligible effects on the systemic circulation.
22